GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Additional Paid-In Capital

NeoPharm Co (XKRX:092730) Additional Paid-In Capital : ₩45,684 Mil(As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Additional Paid-In Capital?


NeoPharm Co's quarterly additional paid-in capital stayed the same from Sep. 2023 (₩45,684 Mil) to Dec. 2023 (₩45,684 Mil) and stayed the same from Dec. 2023 (₩45,684 Mil) to Mar. 2024 (₩45,684 Mil).

NeoPharm Co's annual additional paid-in capital stayed the same from Dec. 2021 (₩45,684 Mil) to Dec. 2022 (₩45,684 Mil) and stayed the same from Dec. 2022 (₩45,684 Mil) to Dec. 2023 (₩45,684 Mil).

NeoPharm Co Additional Paid-In Capital Historical Data

The historical data trend for NeoPharm Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Additional Paid-In Capital Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45,133.18 45,133.18 45,683.69 45,683.69 45,683.69

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45,683.69 45,683.69 45,683.69 45,683.69 45,683.69

NeoPharm Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

NeoPharm Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoPharm Co (XKRX:092730) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:234920 XKRX:078520 XKRX:226320 XKRX:317240 XKRX:362320 XKRX:024720 XKRX:256940 XKRX:123690 XKRX:950140 XKRX:214420 PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT EL KMB KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
Website
http://www.neopharm.co.kr
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines